Effect of oleuropein on oxidative stress, inflammation and apoptosis induced by ischemia-reperfusion injury in rat kidney.


Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
15 Aug 2020
Historique:
received: 09 03 2020
revised: 11 05 2020
accepted: 19 05 2020
pubmed: 26 5 2020
medline: 1 7 2020
entrez: 26 5 2020
Statut: ppublish

Résumé

This study aimed to evaluate the effect of oleuropein (OLE), the main phenolic compound present in olive leaves, on kidney ischemia-reperfusion injury (IRI) and to explore the underlying protective mechanism. Rat kidneys were subjected to 60 min of bilateral warm ischemia followed by 120 min of reperfusion. OLE was administered orally 48 h, 24 h and 30 min prior to ischemia at doses of 10, 50 and 100 mg/kg body weight. The creatinine, urea, uric acid concentrations and lactate dehydrogenase (LDH) activity in plasma were evaluated. Oxidative stress and inflammation parameters were also assessed. Renal expression of AMP-activated protein kinase (p-AMPK), endothelial nitric oxide synthase (eNOS), mitogen-activated protein kinases (MAPK), inflammatory proteins and apoptotic proteins were evaluated using Western blot. Our results showed that OLE at 50 mg/kg reduced kidney IRI as revealed by a significant decrease of plasmatic creatinine, urea, uric acid concentrations and LDH activity. In parallel, OLE up-regulated antioxidant capacities. Moreover, OLE diminished the level of CRP and the expression of cyclooxygenase 2 (COX-2). Finally, OLE enhanced AMPK phosphorylation as well as eNOS expression whereas MAPK, and cleaved caspase-3 implicated in cellular apoptosis were attenuated in the ischemic kidneys. In conclusion, this study shows that OLE could be used as therapeutic agent to reduce IRI through its anti-oxidative, anti-inflammatory and anti-apoptotic properties.

Identifiants

pubmed: 32450167
pii: S0024-3205(20)30583-X
doi: 10.1016/j.lfs.2020.117833
pii:
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Antioxidants 0
Iridoid Glucosides 0
Iridoids 0
oleuropein 2O4553545L

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117833

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Hana Nasrallah (H)

Laboratoire de Génome Humain et Maladies Multifactorielles (LR12ES07), Faculté de Pharmacie de Monastir, Université de Monastir, Tunisia.

Imen Aissa (I)

Laboratoire de Chimie Hétérocyclique, Produits Naturels et Réactivité, équipe: Chimie Médicinale et Produits Naturels (LR11ES39), Faculté des Sciences de Monastir, Université de Monastir, Monastir, Tunisia.

Chérifa Slim (C)

Laboratoire de Génome Humain et Maladies Multifactorielles (LR12ES07), Faculté de Pharmacie de Monastir, Université de Monastir, Tunisia.

Mohamed Ali Boujbiha (MA)

Laboratoire de Bioressources: Biologie Intégrative & Valorisation (LR14ES06), Institut Supérieur de Biotechnologie de Monastir, Université de Monastir, Monastir, Tunisia.

Mohamed Amine Zaouali (MA)

Laboratoire de Génome Humain et Maladies Multifactorielles (LR12ES07), Faculté de Pharmacie de Monastir, Université de Monastir, Tunisia; Département des Sciences du Vivant et Biotechnologie, Institut Supérieur de Biotechnologie de Monastir, Université de Monastir, Monastir, Tunisia. Electronic address: daminzaouali12@yahoo.fr.

Mohamed Bejaoui (M)

Laboratoire de Génome Humain et Maladies Multifactorielles (LR12ES07), Faculté de Pharmacie de Monastir, Université de Monastir, Tunisia.

Victoria Wilke (V)

Laboratoire de Génome Humain et Maladies Multifactorielles (LR12ES07), Faculté de Pharmacie de Monastir, Université de Monastir, Tunisia.

Hichem Ben Jannet (H)

Laboratoire de Chimie Hétérocyclique, Produits Naturels et Réactivité, équipe: Chimie Médicinale et Produits Naturels (LR11ES39), Faculté des Sciences de Monastir, Université de Monastir, Monastir, Tunisia.

Habib Mosbah (H)

Laboratoire de Bioressources: Biologie Intégrative & Valorisation (LR14ES06), Institut Supérieur de Biotechnologie de Monastir, Université de Monastir, Monastir, Tunisia.

Hassen Ben Abdennebi (H)

Laboratoire de Génome Humain et Maladies Multifactorielles (LR12ES07), Faculté de Pharmacie de Monastir, Université de Monastir, Tunisia.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH